266 related articles for article (PubMed ID: 24044630)
1. Niemann-Pick type C1 patient-specific induced pluripotent stem cells display disease specific hallmarks.
Trilck M; Hübner R; Seibler P; Klein C; Rolfs A; Frech MJ
Orphanet J Rare Dis; 2013 Sep; 8():144. PubMed ID: 24044630
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological In Vitro Profile of Neuronal Differentiated Cells Derived from Niemann-Pick Disease Type C2 Patient-Specific iPSCs Carrying the
Liedtke M; Völkner C; Jürs AV; Peter F; Rabenstein M; Hermann A; Frech MJ
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924575
[TBL] [Abstract][Full Text] [Related]
3. Patient-Specific iPSC-Derived Neural Differentiated and Hepatocyte-like Cells, Carrying the Compound Heterozygous Mutation p.V1023Sfs*15/p.G992R, Present the "Variant" Biochemical Phenotype of Niemann-Pick Type C1 Disease.
Völkner C; Liedtke M; Untucht R; Hermann A; Frech MJ
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830064
[TBL] [Abstract][Full Text] [Related]
4. Activation of PKC triggers rescue of NPC1 patient specific iPSC derived glial cells from gliosis.
Peter F; Rost S; Rolfs A; Frech MJ
Orphanet J Rare Dis; 2017 Aug; 12(1):145. PubMed ID: 28841900
[TBL] [Abstract][Full Text] [Related]
5. Generation and Neuronal Differentiation of Patient-Specific Induced Pluripotent Stem Cells Derived from Niemann-Pick Type C1 Fibroblasts.
Trilck M; Hübner R; Frech MJ
Methods Mol Biol; 2016; 1353():233-59. PubMed ID: 25520288
[TBL] [Abstract][Full Text] [Related]
6. Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons.
Trilck M; Peter F; Zheng C; Frank M; Dobrenis K; Mascher H; Rolfs A; Frech MJ
Brain Res; 2017 Feb; 1657():52-61. PubMed ID: 27923633
[TBL] [Abstract][Full Text] [Related]
7. Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy.
Yu D; Swaroop M; Wang M; Baxa U; Yang R; Yan Y; Coksaygan T; DeTolla L; Marugan JJ; Austin CP; McKew JC; Gong DW; Zheng W
J Biomol Screen; 2014 Sep; 19(8):1164-73. PubMed ID: 24907126
[TBL] [Abstract][Full Text] [Related]
8. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
[TBL] [Abstract][Full Text] [Related]
9. Rescue of an in vitro neuron phenotype identified in Niemann-Pick disease, type C1 induced pluripotent stem cell-derived neurons by modulating the WNT pathway and calcium signaling.
Efthymiou AG; Steiner J; Pavan WJ; Wincovitch S; Larson DM; Porter FD; Rao MS; Malik N
Stem Cells Transl Med; 2015 Mar; 4(3):230-8. PubMed ID: 25637190
[TBL] [Abstract][Full Text] [Related]
10. Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems.
Völkner C; Pantoom S; Liedtke M; Lukas J; Hermann A; Frech MJ
Cells; 2022 Jan; 11(3):. PubMed ID: 35159129
[TBL] [Abstract][Full Text] [Related]
11. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.
Mou X; Wu Y; Cao H; Meng Q; Wang Q; Sun C; Hu S; Ma Y; Zhang H
Stem Cell Res Ther; 2012 Apr; 3(2):14. PubMed ID: 22512921
[TBL] [Abstract][Full Text] [Related]
12. Decreased calcium flux in Niemann-Pick type C1 patient-specific iPSC-derived neurons due to higher amount of calcium-impermeable AMPA receptors.
Rabenstein M; Peter F; Joost S; Trilck M; Rolfs A; Frech MJ
Mol Cell Neurosci; 2017 Sep; 83():27-36. PubMed ID: 28666962
[TBL] [Abstract][Full Text] [Related]
13. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
Okada M; Yoneda Y
Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
[TBL] [Abstract][Full Text] [Related]
14. A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1.
Prabhu AV; Kang I; De Pace R; Wassif CA; Fujiwara H; Kell P; Jiang X; Ory DS; Bonifacino JS; Ward ME; Porter FD
BMC Biol; 2021 Oct; 19(1):218. PubMed ID: 34592985
[TBL] [Abstract][Full Text] [Related]
15. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
16. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
[TBL] [Abstract][Full Text] [Related]
17. Inducing Pluripotency in the Domestic Cat (
Dutton LC; Dudhia J; Guest DJ; Connolly DJ
Stem Cells Dev; 2019 Oct; 28(19):1299-1309. PubMed ID: 31389301
[TBL] [Abstract][Full Text] [Related]
18. iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin.
Yan X; Qin H; Qu C; Tuan RS; Shi S; Huang GT
Stem Cells Dev; 2010 Apr; 19(4):469-80. PubMed ID: 19795982
[TBL] [Abstract][Full Text] [Related]
19. Oxidative Stress and Alterations in the Antioxidative Defense System in Neuronal Cells Derived from NPC1 Patient-Specific Induced Pluripotent Stem Cells.
Jürs AV; Völkner C; Liedtke M; Huth K; Lukas J; Hermann A; Frech MJ
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081384
[TBL] [Abstract][Full Text] [Related]
20. Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1.
Völkner C; Liedtke M; Hermann A; Frech MJ
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
